Scope: nomenclature and source matching. This is a curated reference for ambiguous reading tasks, not a list of interchangeable products. The rows preserve the boundary between a study intervention and a supplied material.
Four names that need a second check
| Name | Code or related terminology | What to resolve | Ambiguity warning | Sources |
|---|---|---|---|---|
| CJC-1295 | Long-acting CJC-1295; DAC terminology | Record whether the DAC modification is present and obtain the exact molecular specification | Do not transfer findings to non-DAC material based on the short name | Primary source; evidence dossier |
| TB-500 | Ac-LKKTETQ; N-acetylated thymosin beta-4 fragment | The cited analytical study identified the acetylated 17-23 fragment in tested material | A TB-500 label does not identify every batch; the fragment is not full-length thymosin beta-4 | Primary source; evidence dossier |
| PT-141 | Bremelanotide | Match the molecular entity and the formulation before using clinical evidence | The named intervention in a clinical trial does not authenticate a research vial | Primary source; evidence dossier |
| Retatrutide | LY3437943 | Keep the research code with the compound and study record | A code match does not establish batch identity, content or formulation equivalence | Primary source; evidence dossier |
Download the terminology crosswalk (CSV).
Keep salts, forms and quantities explicit
For your own record, copy the supplier's complete form description, including any stated salt, counterion, complex or modification. If this is absent, enter “not supplied”; this crosswalk intentionally assigns no default salt to a catalogue name. Ask what the quantity refers to and retain the exact wording with the source document.
A reproducible matching procedure
- Copy the label and record its URL and date.
- Locate the source using the name or research code.
- Compare the stated molecular specification and formulation; mark each missing field.
- Keep a separate link to the batch report. A literature match does not authenticate that batch.
- Record who resolved the ambiguity and which document supports the resolution.
The identity glossary defines the terms. The formulation comparison explains why a matching molecule name still leaves a study-transfer question.
Method, ownership and revision record
This original reference organises selected sources by the question a reader needs to resolve. It is not a validated laboratory protocol or an exhaustive review. Version 1.0, reviewed 2026-09-17; next review 2026-12-17. Maintained by the AUS Peptide Supply editorial team, with review ownership assigned to the business operator. Initial release: source-linked comparison and downloadable reference table.
Send corrections through the scientific-document enquiry route. Return to the analytical-quality parent topic or use the supplier worksheet to record an unresolved question.